Gopeshwar Narayan
Overview
Explore the profile of Gopeshwar Narayan including associated specialties, affiliations and a list of published articles.
Author names and details appear as published. Due to indexing inconsistencies, multiple individuals may share a name, and a single author may have variations. MedLuna displays this data as publicly available, without modification or verification
Snapshot
Snapshot
Articles
78
Citations
1667
Followers
0
Related Specialties
Related Specialties
Top 10 Co-Authors
Top 10 Co-Authors
Published In
Affiliations
Affiliations
Soon will be listed here.
Recent Articles
1.
Gupta G, Joshi D, Narayan G, Sharma S
In Silico Pharmacol
. 2025 Mar;
13(1):37.
PMID: 40061632
The misfolding and aggregation of alpha-synuclein play a pivotal role in the pathogenesis of Parkinson's disease (PD), contributing to neuronal dysfunction, the formation of Lewy bodies, and the manifestation of...
2.
Singh J, Narayan G, Dixit V
Dig Liver Dis
. 2024 Mar;
56(10):1776-1783.
PMID: 38556409
Background: Long-intergenic non-protein coding gene 01140 (LINC01140) a long non-coding RNA is highly expressed in various cancers. However, its biological functions in gastric cancer progression is still unknown. Method: To...
3.
Bharti A, Ansari M, Tewari M, Narayan G, Singh S
Dig Dis Sci
. 2023 Dec;
69(2):502-509.
PMID: 38135812
Background: Promoter hypermethylation of tumor suppressor genes has been demonstrated to be one of the major mechanisms of their epigenetic regulation in various reports. We have studied the promoter methylation...
4.
Deepak P, Kumar P, Arya D, Pandey P, Kumar S, Parida B, et al.
Int J Pharm
. 2023 Jun;
642:123160.
PMID: 37379892
Current anticancer drug research includes tumor-targeted administration as a critical component because it is the best strategy to boost efficacy and decrease toxicity. Low drug concentration in cancer cells, nonspecific...
5.
Singh D, Biswas D, Tewari M, Kar A, Ansari M, Singh S, et al.
J Gastrointest Cancer
. 2023 Jan;
54(4):1231-1239.
PMID: 36705780
Background: Oct4 has critical role in maintaining pluripotency, proliferative potential, and self-renewal capacity in embryonic stem and germ cells. Although Oct4 has been shown to be upregulated in many cancers,...
6.
Anjali K, Kumar T, Kar A, Kumar P, Narayan G, Singh S
Dig Liver Dis
. 2022 Dec;
55(6):807-814.
PMID: 36581511
Background: Previously, we have reported that PARP1 rs1136410 is significantly associated with increased the risk of gallbladder cancer. Aim: We aimed to investigate the association of PARP1 rs1805405 and rs3219088...
7.
Ionizing Radiation and Estrogen Affecting Growth Factor Genes in an Experimental Breast Cancer Model
Calaf G, Crispin L, Munoz J, Aguayo F, Roy D, Narayan G
Int J Mol Sci
. 2022 Nov;
23(22).
PMID: 36430763
Genes associated with growth factors were previously analyzed in a radiation- and estrogen-induced experimental breast cancer model. Such in vitro experimental breast cancer model was developed by exposure of the...
8.
Calaf G, Crispin L, Munoz J, Aguayo F, Narayan G, Roy D
Int J Mol Sci
. 2022 Oct;
23(20).
PMID: 36293530
Cancer develops in a multi-step process where environmental carcinogenic exposure is a primary etiological component, and where cell-cell communication governs the biological activities of tissues. Identifying the molecular genes that...
9.
Singh A, Singh A, Mishra O, Prasad R, Narayan G, Batra V, et al.
J Pediatr Genet
. 2022 Aug;
11(3):185-191.
PMID: 35990031
Steroid-resistant nephrotic syndrome (SRNS) patients with genetic mutations most commonly have histology of focal segmental glomerulosclerosis (FSGS) and do not respond to immunosuppressive drugs. We report the molecular screening results...
10.
Anjali K, Kumar T, Kumar P, Narayan G, Singh S
Dig Liver Dis
. 2022 Jul;
54(11):1533-1540.
PMID: 35780063
Background: Deregulation of DNA repair mechanisms have been frequently demonstrated in the pathology of cancers including gallbladder cancer. Aim: We aimed to investigate the association of ERCC4 rs1800067 (G/A) and...